GSK will stop selling its blood cancer drug Blenrep in the United States, it said on Tuesday, representing the latest in a series of setbacks for the Briti..
LONDON, Nov 22 GSK will stop selling its blood cancer drug Blenrep in the United States, it said today, representing the latest in a series of setbacks for the British.